Intellia Therapeutics Market Cap

Intellia Therapeutics has a market cap or net worth of 988.06 million as of February 12, 2026. Its market cap has increased by 20.53% in one year.

Market Cap

988.06M

Enterprise Value

568.23M

Revenue

42.80M

Ranking

n/a

PE Ratio

n/a

Stock Price

11.29

Market Cap Chart

Since May 6, 2016, Intellia Therapeutics's market cap has increased from 537.16M to 988.06M, an increase of 83.94%. That is a compound annual growth rate of 6.43%.

Market Cap History

Date	Market Cap	% Change
Feb 11, 2026	1.02B	31.67%
Dec 31, 2025	773.69M	-18.44%
Dec 31, 2024	948.58M	-55.75%
Dec 29, 2023	2.14B	-13.15%
Dec 30, 2022	2.47B	-62.02%
Dec 31, 2021	6.50B	152.49%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
May 6, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	231.18B
GSK plc	86.28B
Haleon	36.19B
Smith & Nephew	11.10B
HUTCHMED (China)	1.84B
Oxford Nanopore Technologies	1.29B
Oxford Biomedica	986.00M
CVS Group	982.18M

Market Cap Rankings